Severe malaria treatment receives FDA approval
Outbreak News27 Maj 2020

Severe malaria treatment receives FDA approval

Approximately 2,000 US cases of malaria are diagnosed annually. Without appropriate treatment, about 15 percent become severe. Mortality from untreated severe malaria (particularly cerebral malaria) approaches 100 percent.

On Tuesday, the Food and Drug Administration (FDA) approved Artesunate for Injection to Amivas, a Maryland company specializing in treatments for rare and neglected tropical diseases.

Joining me today to talk about severe malaria and the newly approved drug is Bryan Smith, MD. Dr. Smith is the Chief Medical Officer at Amivas.

Det här avsnittet är hämtat från ett öppet RSS-flöde och publiceras inte av Podme. Det kan innehålla reklam.

Avsnitt(535)

Populärt inom Politik & nyheter

svenska-fall
motiv
aftonbladet-krim
p3-krim
spar
aftonbladet-daily
flashback-forever
rss-sanning-konsekvens
rss-expressen-dok
rss-krimreportrarna
rss-vad-fan-hande
svd-ledarredaktionen
rss-frandfors-horna
rss-flodet
rss-aftonbladet-krim
politiken
dagens-eko
spotlight
olyckan-inifran
rss-krimstad